Related Experiment Video
Updated: Feb 6, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Quantitative prediction of long-term molecular response in TKI-treated CML - Lessons from an imatinib versus
Ingmar Glauche1, Matthias Kuhn1, Christoph Baldow1
1Institute for Medical Informatics and Biometry, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany.
Abstract:
Longitudinal monitoring of BCR-ABL transcript levels in peripheral blood of CML patients treated with tyrosine kinase inhibitors (TKI) revealed a typical biphasic response. Although second generation TKIs like dasatinib proved more efficient in achieving molecular remission compared to first generation TKI imatinib, it is unclear how individual responses differ between the drugs and whether mechanisms of drug action can be deduced from the dynamic data. We use time courses from the DASISION trial to address statistical differences in the dynamic response between first line imatinib vs. dasatinib treatment cohorts and we analyze differences between the cohorts by fitting an established mathematical model of functional CML treatment to individual time courses. On average, dasatinib-treated patients show a steeper initial response, while the long-term response only marginally differed between the treatments. Supplementing each patient time course with a corresponding confidence region, we illustrate the consequences of the uncertainty estimate for the underlying mechanisms of CML remission. Our model suggests that the observed BCR-ABL dynamics may result from different, underlying stem cell dynamics. These results illustrate that the perception and description of CML treatment response as a dynamic process on the level of individual patients is a prerequisite for reliable patient-specific response predictions and treatment optimizations.
Insights
Second-generation tyrosine kinase inhibitors (TKIs) like dasatinib offer faster initial responses in chronic myeloid leukemia (CML) treatment compared to imatinib. Individual patient data analysis reveals insights into CML remission mechanisms and personalized treatment optimization.
Area of Science:
- Hematology
- Pharmacology
- Mathematical Biology
Background:
- Longitudinal monitoring of BCR-ABL transcript levels is crucial for assessing tyrosine kinase inhibitor (TKI) efficacy in chronic myeloid leukemia (CML).
- Second-generation TKIs, such as dasatinib, demonstrate improved molecular remission rates compared to first-generation imatinib.
- Understanding individual response dynamics and underlying mechanisms is key for optimizing CML treatment.
Purpose of the Study:
- To statistically compare the dynamic treatment response between imatinib and dasatinib cohorts in first-line CML treatment.
- To analyze differences in treatment response by fitting a mathematical model to individual patient time courses.
- To explore how uncertainty estimates impact the interpretation of CML remission mechanisms.
Main Methods:
- Utilized time course data from the DASISION clinical trial.
- Performed statistical analysis to compare dynamic responses between imatinib and dasatinib treatment groups.
- Applied a mathematical model of CML treatment to individual patient data, incorporating confidence regions.
Main Results:
- Dasatinib-treated patients exhibited a significantly steeper initial BCR-ABL transcript level reduction compared to imatinib.
- Long-term treatment responses showed only marginal differences between the imatinib and dasatinib cohorts.
- Model analysis suggested that observed BCR-ABL dynamics may stem from distinct underlying stem cell dynamics.
Conclusions:
- Individualized dynamic response analysis is essential for accurate patient-specific predictions and treatment optimization in CML.
- The study highlights the importance of considering stem cell dynamics in understanding CML treatment response.
- Mathematical modeling of longitudinal data provides valuable insights into drug efficacy and remission mechanisms.
More Related Videos
09:38Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
Related Concept Videos
Predicting Molecular Geometry
The Sense of Self: Reflected Self-Appraisal and Social Comparison
Molecular Comparison of Gases, Liquids, and Solids
Molecular Orbital Theory II
Long-term Depression
Molecular Compounds: Formulas and Nomenclature